We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$2.67B
AUM Growth
+$327M
Cap. Flow
+$290M
Cap. Flow %
10.89%
Top 10 Hldgs %
50.32%
Holding
72
New
10
Increased
21
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$78.7M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$30.8M
3
NRG icon
NRG Energy
NRG
+$23.8M
4
QDEL icon
QuidelOrtho
QDEL
+$23.7M
5
HRTX icon
Heron Therapeutics
HRTX
+$21.3M

Top Sells

Rank Stock Value
1
VST icon
Vistra
VST
+$66.4M
2
HAPN
Happen Inc
HAPN
+$51.8M
3
STNG icon
Scorpio Tankers
STNG
+$48.8M
4
FLR icon
Fluor
FLR
+$34.7M
5
PARR icon
Par Pacific Holdings
PARR
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.61%
2 Energy 12.33%
3 Industrials 10.22%
4 Financials 7.91%
5 Utilities 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$83B
$265M 9.94%
+1,500,000
New +$282M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$41.2B
$194M 7.27%
19,000,000
+281,638
+2% +$2.62M
GLNG icon
3
Golar LNG
GLNG
$5.13B
$158M 5.92%
6,506,757
+50,000
+0.8% +$1.15M
VTRS icon
4
Viatris
VTRS
$18.9B
$131M 4.9%
13,250,000
+1,300,000
+11% +$13.5M
ROIV icon
5
Roivant Sciences
ROIV
$26.2B
$123M 4.6%
10,500,000
+6,963,562
+197% +$78.7M
BGC icon
6
BGC Group
BGC
$4.89B
$106M 3.96%
20,000,000
– –
COOP
7
DELISTED
Mr. Cooper
COOP
$105M 3.95%
1,965,173
– –
CCJ icon
8
Cameco
CCJ
$42.4B
$100M 3.75%
2,523,540
-171,464
-6% -$6.07M
FLR icon
9
Fluor
FLR
$7.96B
$87.3M 3.28%
2,379,657
-1,034,692
-30% -$34.7M
AIR icon
10
AAR Corp
AIR
$5.76B
$73.1M 2.74%
1,228,422
– –
COLL icon
11
Collegium Pharmaceutical
COLL
$956M
$71M 2.66%
3,175,000
-250,000
-7% -$5.7M
PARR icon
12
Par Pacific Holdings
PARR
$3.32B
$70.9M 2.66%
1,972,181
-722,029
-27% -$23.7M
HTZ icon
13
Hertz
HTZ
$809M
$63.3M 2.37%
5,165,254
-555,636
-10% -$9.29M
MATV icon
14
Mativ Holdings
MATV
$711M
$57M 2.14%
4,000,000
+562,422
+16% +$9M
RNW icon
15
ReNew
RNW
$2.25B
$53.7M 2.02%
9,897,426
+1,731,521
+21% +$10.2M
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$5.93B
$53.5M 2.01%
3,077,449
-300,715
-9% -$5.07M
NRG icon
17
NRG Energy
NRG
$24.8B
$50.8M 1.9%
1,318,020
+629,993
+92% +$23.8M
ADEA icon
18
Adeia
ADEA
$3.11B
$49.6M 1.86%
4,640,009
+47,448
+1% +$504K
ANIP icon
19
ANI Pharmaceuticals
ANIP
$1.78B
$49.2M 1.84%
847,011
– –
KOP icon
20
Koppers
KOP
$969M
$45M 1.69%
1,138,592
+73,151
+7% +$2.77M
OFIX icon
21
Orthofix Medical
OFIX
$419M
$44.2M 1.66%
3,434,665
+1,042,253
+44% +$18.8M
DOLE icon
22
Dole
DOLE
$1.32B
$43.3M 1.63%
3,742,152
+104,474
+3% +$1.31M
PTVE
23
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$40.6M 1.52%
5,000,000
+184,217
+4% +$1.51M
XPER icon
24
Xperi
XPER
$348M
$39.9M 1.5%
4,043,744
+200,000
+5% +$2.36M
HOLI
25
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$38.5M 1.44%
1,941,237
– –
1
2 3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2023 Portfolio in Review

As of Q3 2023, Rubric Capital Management (New York) held 72 positions worth $2.67B, up 14% from $2.34B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Rubric Capital Management (New York) deployed $290M of net new capital in Q3 2023, opening 10 new positions and adding to 21 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 1,600,000 shares worth $18.4M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 33% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Vistra, an estimated $66.4M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2023 buy was Revance Therapeutics, Inc.: 1,600,000 shares worth $18.4M.
  • Rubric Capital Management (New York) added most to Roivant Sciences in Q3 2023, an estimated $78.7M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2023 reduction was Vistra, cutting an estimated $66.4M.
  • Rubric Capital Management (New York) fully exited Happen Inc in Q3 2023, selling an estimated $51.8M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 50% of its $2.67B portfolio in Q3 2023.
  • Rubric Capital Management (New York) opened 10 new positions and closed 11 in Q3 2023.
  • Rubric Capital Management (New York)'s portfolio value rose 14% quarter-over-quarter to $2.67B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.